Hagita, Sumihiko

Dr. Sumihiko Hagita received his Ph.D. in medicine at Tokyo Medical and Dental University in 2011. After graduation, he began working for Kowa Company, Limited in 2011 and was assigned to the diabetes research group in the Pharmacology Department at Tokyo New Drug Research Laboratories. He performed research studies to evaluate new drugs or compounds for type 2 diabetes mellitus.
He has been working on elucidation of the mechanisms underlying arterial calcification to find new therapeutic target preventing cardiovascular calcification.